000			02363 a2200613 4500
005			20250517223142.0
264		0	_c20190910
008			201909s 0 0 eng d
022			_a1537-6613
024	7		_a10.1093/infdis/jiy214 _2doi
040			_aNLM _beng _cNLM
100	1		_ade Vries, Rory D
245	0	0	_aInduction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial. _h[electronic resource]
260			_bThe Journal of infectious diseases _c07 2018
300			_a614-623 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAdult
650	0	4	_aAntibodies, Viral _xblood
650	0	4	_aAntibody-Dependent Cell Cytotoxicity
650	0	4	_aCross Reactions
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Carriers
650	0	4	_aFemale
650	0	4	_aHemagglutination Inhibition Tests
650	0	4	_aHemagglutinin Glycoproteins, Influenza Virus _xgenetics
650	0	4	_aHumans
650	0	4	_aImmunization Schedule
650	0	4	_aInfluenza A Virus, H5N1 Subtype _xgenetics
650	0	4	_aInfluenza Vaccines _xadministration & dosage
650	0	4	_aInfluenza, Human _xprevention & control
650	0	4	_aMale
650	0	4	_aNeutralization Tests
650	0	4	_aProtein Array Analysis
650	0	4	_aT-Lymphocytes _ximmunology
650	0	4	_aVaccines, Synthetic _xadministration & dosage
650	0	4	_aVaccinia virus _xgenetics
650	0	4	_aYoung Adult
700	1		_aAltenburg, Arwen F
700	1		_aNieuwkoop, Nella J
700	1		_ade Bruin, Erwin
700	1		_avan Trierum, Stella E
700	1		_aPronk, Mark R
700	1		_aLamers, Mart M
700	1		_aRichard, Mathilde
700	1		_aNieuwenhuijse, David F
700	1		_aKoopmans, Marion P G
700	1		_aKreijtz, Joost H C M
700	1		_aFouchier, Ron A M
700	1		_aOsterhaus, Albert D M E
700	1		_aSutter, Gerd
700	1		_aRimmelzwaan, Guus F
773	0		_tThe Journal of infectious diseases _gvol. 218 _gno. 4 _gp. 614-623
856	4	0	_uhttps://doi.org/10.1093/infdis/jiy214 _zAvailable from publisher's website
999			_c28540019 _d28540019